Revolutionary Randox Technology Offers Multiple Cardiac Tests within Minutes Presented at Medica 2009

A new revolutionary Biochip Analyser that will save cardiac patients lives by providing immediate diagnosis at the point of care is to be launched by Randox at Medica 2009. The Randox Evidence MultiStat is a revolutionary benchtop analyser which offers up to 8 cardiac results within just 20 minutes. To find out more visit hall 3, booth A08.

This innovative new technology ensures the accuracy and precision of a commercial laboratory analyser within the A & E department delivering significant benefits for those patients with chest pains by rapidly identifying risk and enabling accurate clinical decisions.

With some blood biomarkers only detectable for 6 hours after a heart attack, patients presenting with early symptoms are often missed. The Evidence MultiStat will ultimately save patient lives by giving accurate and timely diagnosis when time is at a premium.

The Evidence MultiStat is based upon the award winning Biochip technology from Randox and utilises the precision and accuracy of the commercially available lab based Evidence analyser giving the Evidence MultiStat distinct advantages.

The Evidence MultiStat also offers an array for drugs of abuse with arrays for stroke, metabolic syndrome, cancer, fertility disorders, thyroid disorders, synthetic steroids and additional drugs of abuse currently in development. The system is suitable for a variety of point of patient environments including emergency departments, cardiac units, doctor surgeries, forensic units, rehab units and employee drug screening centres. The technology offers fully automated pipetting, incubation, washing, imaging and report generation ensuring that the MultiStat can be used by non technical staff. User friendly touch screen Windows ® based software also ensures little or no training is required.

Randox have developed a comprehensive test menu that can work with a wide range of sample matrix including urine and serum with plasma and whole blood currently in development. The Cardiac Arrays includes CK-MB, FABP, Myoglobin and Cardiac Troponin with the Drugs of Abuse Array including multiple analytes such as Amphetamine, Barbiturates, Benzadiazepine, Cannabinoids and Cocaine